Behavioral Neuroscience – News and Features

Findings may provide the foundation for a test to complement standard clinical diagnosis, potentially enabling earlier intervention and treatment.

The drug warfarin may help prevent liver failure in thousands of people with Hepatitis C, according to new research.

Researchers have pinpointed a mechanism in the brains of mice that could explain why some human mothers become depressed following childbirth.

A new drug has been shown to improve the brain function of Alzheimer's patients and reduce a key protein associated with the disease in the spinal fluid.

Researchers developed a computational method that compares how similar the side effects of different drugs are and predicts how likely the drugs act on the same target molecule.

Phase 2 study shows that Dimebon™ significantly improved cognitive function in patients with mild-to-moderate Huntington’s disease.

The study showed in both young and elderly subjects that EVT 101 was well tolerated up to the highest dose tested.

Illumina's Infinium HD Human1M-Duo BeadChip to be used to analyze 90,000 DNA samples collected from study participants.

Deficiency of the FMR1 gene and a similar gene called FXR2 could account for sleep problems associated with inherited mental impairment.

The Company has commenced clinical trials of a potent, brain penetrant and orally active antagonist at a nonperipheral CNS receptor site 5-HT6.